HIV Mutation Detail Information

> V106M Search Result


Mutation Information
Mutation Site V106M
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Genotype/Subtype C
Relevant Drug efavirenz (EFV);nevirapine (NPV)
Country South Africa
Literature Information
PubMed PMID 22293461
Disease HIV infection/AIDS
Published Year 2012
Journal Antiviral therapy
Title Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy.
Author Wallis CL,Papathanasopolous MA,Fox M,Conradie F,Ive P,Orrell C,Zeinecker J,Sanne I,Wood R,McIntyre J,Stevens W,CIPRA-SA project 1 study team.
Evidence Both the K103N and V106M mutations occurred more frequently in EFV- than NVP-exposed subjects, but differences were not significant (51% vs. 32%, p=0.0064 and 16% vs. 9%, p=0.1345, respectively).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation